Leap Therapeutics/ US52187K2006 /

10/3/2023 8:00:21 PM	Chg. +0.29	Volume	Bid8:00:22 PM	Ask8:00:22 PM	High	Low
1.58USD	+22.48%	25,085 Turnover: 38,061.08	1.44Bid Size: 100	1.73Ask Size: 100	1.59	1.26

GlobeNewswire 12/11/2021 Annual Changes to the Nasdaq Biotechnology Index

GlobeNewswire 3/2/2020 BeiGene Reports Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire 4/12/2019 Factors of Influence in 2019, Key Indicators and Opportunity within IDEXX Laboratories, Aegion, NetS...

GlobeNewswire 1/29/2019 Report: Developing Opportunities within Match Group, Antero Resources, Boyd Gaming, Gorman-Rupp, Lea...

GlobeNewswire 12/20/2018 Oncology Pipeline Analytics Market, 2018-2024 - Drug Development Challenges / Leading Development-St...

GlobeNewswire 8/22/2018 Recent Analysis Shows Leap Therapeutics, Gardner Denver, Medical Transcription Billing, CarGurus, Li...

GlobeNewswire 8/8/2018 Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results

GlobeNewswire 7/23/2018 Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluat...

GlobeNewswire 6/13/2018 Analysis: Positioning to Benefit within Ruth's Hospitality Group, S&P Global, Shaw Communications, L...

GlobeNewswire 6/13/2018 Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference

GlobeNewswire 5/11/2018 Leap Therapeutics Reports First Quarter 2018 Financial Results

GlobeNewswire 4/16/2018 Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting

GlobeNewswire 3/28/2018 New Research Coverage Highlights Holly Energy Partners, Liberty Property Trust, Fair Isaac, 58, Cous...

GlobeNewswire 3/27/2018 Leap Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwri...

GlobeNewswire 3/23/2018 Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock

GlobeNewswire 3/22/2018 Leap Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire 3/21/2018 Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference

GlobeNewswire 3/14/2018 Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annu...

GlobeNewswire 3/7/2018 Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference

GlobeNewswire 2/23/2018 Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of ...

GlobeNewswire 2/7/2018 Cancer Stem Cell Therapies Market, 2030

GlobeNewswire 2/6/2018 Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference

GlobeNewswire 11/15/2017 Leap Therapeutics Announces $18 Million Private Placement Offering

GlobeNewswire 11/13/2017 Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed wit...

GlobeNewswire 9/25/2017 Cancer Immunotherapy Market Research Report: Building on Initial Successes to Improve Clinical Outco...